CYP19A1 and breast cancer: Among the types of HT, tamoxifen (TMX) is highlighted as a selective ER modulator recommended for premenopausal women(3), while aromatase inhibitors (AIs), such as exemestane, letrozole, and anastrozole (ANTZ), are used for postmenopausal women with breast cancer.